Multiple evidence for an early age pro-oxidant state in Down Syndrome patients

Biogerontology

Volumn 7, Issue 4, 2006, Pages 211-220

  Pallardó, Federico V ^a   Degan, Paolo ^b   d'ischia, Marco ^c   Kelly, Frank J ^d   Zatterale, Adriana ^e   Calzone, Rita ^e   Castello, Giuseppe ^b   Fernandez Delgado, Rafael ^f   Dunster, Christina ^d   Lloret, Ana ^a   Manini, Paola ^c   Pisanti, Maria Antonietta ^g   Vuttariello, Emilia ^b   Pagano, Giovanni ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e Elena d'Aosta Hospital   (Italy)

^f UNIVERSITY OF VALENCIA   (Spain)

^g CARDARELLI HOSPITAL   (Italy)

Author keywords

8 hydroxy 2 deoxyguanosine; Down syndrome; Glutathione; Glyoxal; Methylglyoxal; Plasmaantioxidants; Pro oxidant state

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLYOXAL; METHYLGLYOXAL; URIC ACID; XANTHINE OXIDASE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGING; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VIVO STUDY; INFANT; LEUKOCYTE; MALE; ONSET AGE; OXIDATIVE STRESS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

ADOLESCENT; ADULT; AGE FACTORS; AGING; CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 33747256270     PISSN: 13895729     EISSN: 15736768     Source Type: Journal    
DOI: 10.1007/s10522-006-9002-5     Document Type: Article

References (51)

1. Aragno M, Parola S, Brignardello E, Mauro A, Tamagno E, Manti R, Manti R, Danni O, Boccuzzi G (2000) Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats Diabetes 49: 1924-1931
2. Asensi M, Sastre J, Pallardó FV, Estrela JM, Viña J, (1994) High performance liquid chromatography determination of oxidized glutathione in blood Meth Enzymol 234: 367-371
3. Aukrust P, Muller F, Svardal AM, Ueland T, Berge RK, Froland SS, (2003) Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy-potential immunomodulatory effects of antioxidants J Infect Dis 188: 232-238
4. Balcz B, Kirchner L, Cairns N, Fountoulakis M, Lubec G, (2001) Increased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down syndrome and Alzheimer's disease J Neural Transm Suppl 61: 193-201
5. Beckman KB, Ames BN, (1998) The free radical theory of aging matures Physiol Rev 78: 547-581
6. Benzi G, Pastoris O, Marzatico F, Villa RF, (1989) Age-related effect induced by oxidative stress on the cerebral glutathione system Neurochem Res 14: 473-481
7. Borrás C, Gambini J, Gómez-Cabrera MC, Sastre J, Pallardó FV, Mann GE, Viña J, (2005) 17β-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2 [MAPK]/NFκB cascade Aging Cell 4: 113-118
8. Brooksbank BW, Balasz R, (1984) Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Down's syndrome fetal brain Exp Brain Res 16: 37-44
9. Busciglio J, Yankner BA, (1995) Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro Nature 378: 776-779
10. Choudhary D, Chandra D, Kale RK, (1997) Influence of methylglyoxal on antioxidant enzymes and oxidative damage Toxicol Lett 93: 141-152
11. de Haan JB, Susil B, Pritchard M, Kola I, (2003) An altered antioxidant balance occurs in Down syndrome fetal organs: Implications for the "gene dosage effect" hypothesis J Neural Transm Suppl 67: 67-83
12. Desco M, Asensi M, Marquez R, Martinez-Valls J, Vento M, Pallardo F, Sastre J, Viña J, (2002) Xanthine oxidase is involved in free radical production in type 1 diabetes: Protection by allopurinol Diabetes 51:1118-1124
13. Epstein CJ, Avraham KB, Lovett M, Smith S, Elroy-Stein O, Rotman G, Bry C, Groner Y, (1987) Transgenic mice with increased Cu/Zn-superoxide dismutase activity: Animal model of dosage effects in Down syndrome Proc Natl Acad Sci USA 84: 8044-8048
14. Espinosa-Mansilla A, Durán-Merás I, Salinas F, (1998) High-performance liquid chromatographic-fluorometric determination of glyoxal, methylglyoxal, and diacetyl in urine by prederivatization to pteridinic rings Anal Biochem 255: 263-273
15. Fang J, Alderman M, (2000) Serum uric acid and cardiovascular mortality. The NHANES I epidemiologic follow-up study JAMA 283: 2404-2410
16. Giannattasio A, Girotti M, Williams K, Hall L, Bellastella A, (1997) Puberty influences expression of phospholipid hydroperoxide glutathione peroxidase (GPX4) in rat testis: Probable hypophysis regulation of the enzyme in male reproductive tract J Endocrinol Invest 20: 439-444
17. Granger DN, (1994) Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury Am J Physiol 266:H1269-1275
18. Groner Y, Elroy-Stein O, Avraham KB, Schickler M, Knobler H, Minc-Golomb D, Bar-Peled O, Yarom R, Rotshenker S, (1994) Cell damage by excess CuZnSOD and Down's syndrome Biomed Pharmacother 48: 231-240
19. Harman D, (1956) Aging: A theory based on free radical and radiation chemistry J Gerontol 11: 298-300
20. H, (2001) Pattern of malignant disorders in individuals with Down's syndrome Lancet Oncol 2:429-436
21. Hayes A, Batshaw ML, (1993) Down syndrome Pediatr Clin North Am 40: 523-535
22. Iriyama K, Yoshiura M, Iwamoto T, Ozaki Y, (1984) Simultaneous determination of uric and ascorbic acids in human serum by reversed-phase high-performance liquid chromatography with electrochemical detection Anal Biochem 141: 238-243
23. Johnson R, Kang D, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M, (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41: 1183-1190
24. Jones DP, Mody VC Jr, Carlson JL, Lynn MJ, Sternberg P Jr, (2002) Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses Free Radic Biol Med 33: 1290-1300
25. Jovanovic SV, Clements D, MacLeod K, (1998) Biomarkers of oxidative stress are significantly elevated in Down syndrome Free Radic Biol Med 25: 1044-1048
26. Kedziora J, Bartosz G, (1988) Down's syndrome: A pathology involving the lack of balance of reactive oxygen species Free Rad Biol Med 4: 317-330
27. Kelly FJ, Rodgers W, Handel J, Smith S, Hall MA, (1990) Time course of vitamin E repletion in the preterm infant Brit J Nutr 63: 631-638
28. Kennedy BP, Rao F, Botiglieri T, Sharma S, Lillie EO, Ziegler MG, O'Connor DT, (2005) Contributions of the sympathetic nervous system, glutathione, body mass and gender to blood pressure increase with normal aging: Influence of heredity J Hum Hypertens 19: 951-969
29. Labudova O, Kitzmueller E, Rink H, Cairns N, Lubec G, (1999) Increased phosphoglycerate kinase in the brains of patients with Down's syndrome but not with Alzheimer's disease Clin Sci 96: 279-285
30. Lee BM, Kwack SJ, Kim HS, (2005) Age-related changes in oxidative DNA damage and benzo(a)pyrene diolepoxide-I (BPDE-I)-DNA adduct levels in human stomach J Toxicol Environ Health A 68: 1599-1610
31. Lopez-Diazguerrero NE, Luna-Lopez A, Gutierrez-Ruiz MC, Zentella A, Königsberg M, (2005) Susceptibility of DNA to oxidative stressors in young and aging mice Life Sci 77: 2840-2854
32. Lott IT, Head E, (2001) Down syndrome and Alzheimer's disease: A link between development and aging Ment Retard Dev Disabil Res Rev 7: 172-178
33. Medvedev Z, (1990) An attempt at a rational classification of theories of aging Biol Rev Camb Philos Soc 65:375-398
34. Migliore L, Fontana I, Trippi F, Colognato R, Coppede F, Tognoni G Nucciarone B, Siciliano G, (2005) Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients Neurobiol Aging 26: 567-573
35. Muchová J, Šustrová M, Garaiová I, Liptaková A, Blaziček P, Kvasnická P, Pueschel S, Duračková Z, (2001) Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of Down syndrome patients Free Radic Biol Med 31: 499-508
36. Musiani P, Valitutti S, Castellino F, Larocca LM, Maggiano N, Piantelli M, (1990) Intrathymic deficient expansion of T cell precursors in Down syndrome Am J Med Genet Suppl 7: 219-224
37. Nagyová A, Šustrová M, Raslová K, (2000) Serum lipid resistance to oxidation and uric acid levels in subjects with Down's syndrome Physiol Res 49: 227-231
38. ÓHara Y, Peterson T, Harrison D, (1993) Hypercholesterolemia increases endothelial superoxide anion production J Clin Invest 91: 2546-2551
39. Pagano G, Degan P, d'Ischia M, Kelly FJ, Pallardó FV, Zatterale A, Anak SS, Akişik EE, Beneduce G, Calzone R, De Nicola E, Dunster C, Lloret A, Manini P, Nobili P, Saviano A, Vuttariello E, Warnau M, (2004) Gender- and age-related distinctions for the in vivo pro-oxidant state in Fanconi anaemia patients Carcinogenesis 25: 1899-1909
40. Park E, Alberti J, Mehta P, Dalton A, Sersen E, Schuller-Levis G (2000) Partial impairment of immune functions in peripheral blood leukocytes from aged men with Down's syndrome Clin Immunol 95: 62-99
41. Pastor MC, Sierra C, Dolade M, Navarro E, Brandi N, Cabre E, Mira A, Seres A, (1998) Antioxidant enzymes and fatty acid status in erythrocytes of Down's syndrome patients Clin Chem 44: 924-929
42. Patetsios P, Song M, Shutze W, Papas C, Rodino W, Ramírez J, Panetta TF, (2001) Identification or uric acid and xanthine oxidase in atherosclerotic plaque Am J Cardiol 88: 188-191
43. Pratico D, Iuliano L, Amerio G, Tang LX, Rokach J, Sabatino G, Violi F, (2000) Down's syndrome is associated with increased 8,12-iso-iPF2alpha-VI levels: Evidence for enhanced lipid peroxidation in vivo Ann Neurol 48: 795-798
44. Richard JP (1993) Mechanism for the formation of methylglyoxal from triosephosphates Biochem Soc Trans 21: 549-553
45. Rose IA, Nowick JS, (2002) Methylglyoxal synthetase, enol-pyruvaldehyde, glutathione and the glyoxalase system J Am Chem Soc 124: 13047-13052
46. Schmidt AJ, Krieg JC, Vedder H, (2002) Differential effects of glucocorticoids and gonadal steroids on glutathione levels in neuronal and glial cell systems J Neurosci Res 67: 544-550
47. Schwartz CJ, Valente AJ, Sprague EA, (1993) A modern view of atherosclerosis Am J Cardiol 71: 9B-14B
48. Taddei S, Virdis A, Mattei P, Ghiadoni L, Fasolo C, Sudano I, Salvetti A, (1997) Hypertension causes premature aging of endothelial function in humans Hypertension 29: 736-743
49. Ukai T, Cheng C, Tachibana H, Igawa A, Zhang Z, Cheng H, Little WC, (2001) Allopurinol enhances the contractile response to dobutamine and exercise in dogs with pacing-induced heart failure Circulation 103: 750-755
50. Warnholtz A, Wendt M, August M, Munzel T, (2004) Clinical aspects of reactive oxygen and nitrogen species Biochem Soc Symp 71: 121-133
51. Žitňanová I, Korytar P, Aruoma OI, Šustrová M, Garaiová I, Muchová J, Kalnovičová T, Pueschel S, Duračková Z, (2004) Uric acid and allantoin levels in Down syndrome: Antioxidant and oxidative stress mechanisms? Clin Chim Acta 341: 139-146